Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Cash Flow-to-Debt Ratio
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2024, meaning its operating cash flow of CN¥146.50 Million could theoretically repay 0% of its total liabilities (CN¥3.74 Billion) in one year. See 605077 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Huakang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Zhejiang Huakang Pharmaceutical Co Ltd across 9 annual periods. Also explore Zhejiang Huakang Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Zhejiang Huakang Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Zhejiang Huakang Pharmaceutical Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | CN¥146.50 Million | CN¥3.74 Billion | ▼ -80.5% |
| 2023 | 0.20x | CN¥619.47 Million | CN¥3.08 Billion | ▼ -7.5% |
| 2022 | 0.22x | CN¥271.98 Million | CN¥1.25 Billion | ▼ -53.1% |
| 2021 | 0.46x | CN¥264.32 Million | CN¥569.56 Million | ▼ -32.1% |
| 2020 | 0.68x | CN¥335.24 Million | CN¥490.16 Million | ▲ +14.1% |
| 2019 | 0.60x | CN¥281.31 Million | CN¥469.20 Million | ▲ +158.3% |
| 2018 | 0.23x | CN¥140.97 Million | CN¥607.22 Million | ▲ +48.2% |
| 2017 | 0.16x | CN¥80.56 Million | CN¥514.17 Million | ▼ -8.0% |
| 2016 | 0.17x | CN¥93.02 Million | CN¥546.03 Million | — |